ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
5762	Centers for Disease Control and Prevention	Html	en	Morpholine - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
8135	Centers for Disease Control and Prevention	Html	en	Preconception Care, Show Your Love Campaign - Images, Physical Activity	null	Save target 0.868127 right click 0.950907	Save link 0.813989	CLICK HERE
8861	Centers for Disease Control and Prevention	Html	en	Update: Severe Respiratory Illness Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Worldwide, 2012-2013	CDC continues to work in consultation with the World Health Organization (WHO) and other partners to better understand the public health risk posed by the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), formerly known as novel coronavirus, which was first reported to cause human infection in September 2012 (1–4). The continued reporting of new cases indicates that there is an ongoing risk for transmission to humans in the area of the Arabian Peninsula. New reports of cases outside the region raise concerns about importation to other geographic areas.	mild respiratory illnesses 0.336654 CDC 0.298428 stool specimens 0.232744 east respiratory syndrome 0.862637 CDC Emergency Operations 0.248077 respiratory tract specimens 0.458054 rRT-PCR assay 0.226509 novel coronavirus 0.364392 public health risk 0.256898 human-to-human transmission 0.235158 bronchial wash 0.235102 World Health Organization 0.464911 patients 0.242219 syndrome coronavirus infections 0.272819 severe respiratory disease 0.448345 illness onset 0.240515 Arabian Peninsula 0.521915 probable case 0.234334 respiratory illness 0.531608 United States 0.226309 mild respiratory illness 0.402984 infection control 0.312646 health-care personnel 0.236944 Saudi Arabia 0.511118 M. Novel coronavirus 0.272612	respiratory symptoms 0.358412 severe acute respiratory 0.372243 infection control precautions 0.235281 incubation period 0.24003 laboratory-confirmed cases 0.257012 eastern Saudi Arabia 0.348198 local health departments 0.327905 lower respiratory tract 0.660073 public health 0.305069 website (http://www.cdc.gov/coronavirus/mers/case-def.html). 0.228034 acute respiratory illness 0.526418 respiratory tract specimen 0.325979 Middle East Respiratory 0.772445 cases 0.401287 United Arab Emirates 0.429725 MERS-CoV infection 0.3544 clinical respiratory 0.274808 local public health 0.23343 respiratory syndrome coronavirus 0.91219 patient-to-patient nosocomial transmission 0.243653 close contacts 0.366844 infection control procedures 0.262452 bronchoalveolar lavage 0.311222 Coronavirus Study Group 0.270784	CLICK HERE
8937	Centers for Disease Control and Prevention	Html	en	Vaccine Information Statement: Meningococcal - Vaccines - CDC	Meningococcal ACWY (MenACWY and MPSV4) Vaccine Information Statement	meningococcal disease outbreak 0.630598 health care provider 0.71061 Page 0.500266 National Vaccine Injury 0.589594 skin grafts 0.461629 severe allergic reaction 0.788738 additional doses 0.490304 College freshmen 0.459565 MenACWY vaccine 0.573861 meningococcal ACWY vaccine 0.806677 severe allergy 0.474904 Vaccine Adverse Event 0.591278 VAERS website 0.46358 nervous system problems 0.45979 life-threatening allergic reaction 0.526361 meningococcal disease 0.961696 booster dose 0.464292 young adults 0.465486 previous dose 0.463867 single dose 0.464453 U.S. military recruits 0.506201 persistent complement component 0.505904 Drug Administration 0.459012 N. meningitidis 0.530702 certain groups 0.462492	certain people 0.48818 meningococcal vaccines 0.585695 lengthy contact 0.461896 meningococcal conjugate vaccine 0.737923 Meningococcal ACWY vaccines 0.636693 state health department 0.498133 mild illness 0.459019 close contact 0.460951 spinal cord 0.46052 vaccine package insert 0.596395 Current Edition Date 0.520539 booster doses 0.485107 vaccine safety site 0.595797 severe pain 0.470414 people 0.588597 preferred vaccine 0.564095 certain vaccines 0.46355 routine vaccination 0.468286 certain medical conditions 0.612738 Neisseria meningitidis. 0.468269 vaccine 0.832654 different meningococcal vaccine 0.7393 severe scars 0.482096 meningococcal polysaccharide vaccine 0.739322	CLICK HERE
10529	Centers for Disease Control and Prevention	Html	en	Email Updates: January 3, 2012'Clinicians Outreach and Communication Activity (COCA)	CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism.	CDC 0.932809 Local leaders 0.418806 great time 0.403343 Emergency Preparedness 0.446638 recovery measures 0.410324 CDC website 0.623382 interactive sessions 0.409322 Weekly Flu View 0.509053 risk communication principles 0.504797 EID Home Page 0.503293 multi-state outbreaks 0.424745 non-Federal organizations 0.403658 TB prevention 0.451189 Preparedness Summit pre-session 0.54134 122-Cities Mortality Reporting 0.480095 best partnership-communications practices 0.500868 winter emergencies 0.410737 weather-related health problems 0.536239 extremely cold weather 0.49242 action plan 0.411635 extreme cold-weather conditions 0.491249 Carbon Monoxide 0.404685 Environmental Public Health 0.553456 Winter Sports 0.417012 foodborne illness cases 0.466984	Winter Weather 0.418405 New Media Outreach 0.501378 flu vaccine 0.416778 COCA Email Update 0.512279 Infectious disease outbreaks 0.505915 MMWR weekly reports 0.485369 TB program staff 0.530269 Building Support 0.410087 health care workers 0.893107 CDC Current Outbreak 0.688043 public cooperation 0.425031 Communications Planning 0.410218 Specific Hazards preparedness 0.536828 Dec 0.409613 Health Partners Outreach 0.548055 preventive action 0.405963 food safety systems 0.471899 in-person training centers 0.493941 Tracking Network 0.40624 Public Health Preparedness 0.703939 best defense 0.405198 Health Preparedness Summit 0.698798 warmer weather 0.403095 news conference 0.415831	CLICK HERE
12405	Centers for Disease Control and Prevention	Image	null	Motor Vehicle Prioritizing Interventions and Cost Calculator for States (1175W x 347H)	null			CLICK HERE
12473	Centers for Disease Control and Prevention	Video	en	June 2013 ACIP Meeting -- Pertussis Vaccines	Introduction by Dr. M Sawyer. Pertussis in the United States and Tdap vaccine effectiveness by Dr. A Acosta. Tdap revaccination: safety and immunogenicity by Dr. J Liang. Decision and cost effectiveness analysis: a second dose of Tdap by Dr. M. Messonnier, Dr. H Kamiya. Work group conclusions on a second dose of Tdap by Dr. J Liang. Maternal Tdap and cocooning: experiences from Australia and the United Kingdom by Dr. P McIntyre, Dr. D Salisbury. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=8a1f7d5638cd206be3b576b1969e0f0520130730141810953	Pertussis Vaccines 0.926187	ACIP Meeting 0.777255	CLICK HERE
12542	Centers for Disease Control and Prevention	Video	en	CDC: Erica's Story, Let's Stop HIV Together	In this digital story, Erica talks about living with HIV as a transgender woman and reassures others that it is okay to be open, discuss your HIV status, and live your best life. The more educated people are about HIV, the better they are at protecting themselves and protecting others. Let's Stop HIV Together is a national HIV awareness and anti-stigma campaign produced by the Centers for Disease Control and Prevention (CDC). It features stories of individuals living with HIV and the people who support them. Join the conversation on Facebook at www.facebook.com/ActAgainstAIDS. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=c4c3da593e1399fd4e132b1b2dda304620131122093611390	CDC 0.701155 Erica 0.734362	YouTube 0.672781	CLICK HERE
14433	Centers for Disease Control and Prevention	Html	en	Brucellosis | Risk of Exposure	Information on the risk of exposure to brucellosis infection.	settings 0.22956 Wildlife Services 0.564475 unpasteurized milk 0.807431 occupations 0.284258 Photo courtesy 0.643975 mothers 0.237064	exposure 0.221952 United States Department 0.971575 brucellosis 0.946628 Plant Health Inspection 0.962075 dairy products 0.627545 increased risk 0.5961	CLICK HERE
15913	Centers for Disease Control and Prevention	Html	null	Medication Adherence | Million Hearts	Medication Adherence			CLICK HERE